Average Co-Inventor Count = 3.87
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (12 from 3,923 patents)
2. Glaxo Group Limited (2 from 1,168 patents)
3. Glaxosmithkline Intellectual Property Development Limited (2 from 230 patents)
4. Glaxogrouplimited (1 from 8 patents)
5. Gliapharm Sa (1 from 4 patents)
18 patents:
1. 11925632 - Isoquinoline derivatives for use in treating GLUT1 deficiency syndrome
2. 9849117 - Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
3. 9567343 - Aza-bicyloalkyl ethers and their use as alpha7-nachr agonists
4. 9102653 - Substituted quinazolinones as vanilloid antagonists
5. 9012451 - Aza-bicycloalkyl ethers and their use as ALPHA7-nachr agonists
6. 8809528 - Quinazolinone derivatives useful as vanilloid antagonists
7. 8765743 - Compounds
8. 8658635 - Benzpyrazol derivatives as inhibitors of PI3 kinases
9. 8536169 - Compounds
10. 8357716 - Pyrazole derivatives used as CCR4 receptor antagonists
11. 8236803 - Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists
12. 8211902 - Quinazolinone derivatives useful as vanilloid antagonists
13. 8163743 - 4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases
14. 7960399 - Quinazolinone derivatives useful as vanilloid antagonists
15. 7732435 - Chromone derivatives useful as antagonists of VR1 receptors